Research Network (United States)

company US
4
Publications
15,901
Citations
3
Researchers

Publications

View All

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Purpose: Trastuzumab-based therapy improves survival for women with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. We conducted a multicenter p...

2003 Journal of Clinical Oncology 343 citations

Affiliated Researchers

Institution Info

Type
company
Country
US
Publications
4
Citations
15,901

External Links

Identifiers

ROR
https://ror.org/04tgjxk96